17 July 2014

A recall notice was issued today for Amoxicillin Actavis 125mg/5mL and 250mg/5mL powder for oral suspension. This was because of a notice from Actavis, the manufacturer, to Medsafe that glass fragments had been found in two bottles of the powder. 

This is a consumer-level recall, which means that pharmacists will be contacting all patients who have been prescribed this medicine since 7 July. It is understood that this could involve between 10,000 and 20,000 prescriptions.

The NZMA, along with the Royal New Zealand College of General Practitioners, GPNZ, the Pharmacy Guild and the Pharmaceutical Society, has been in discussions with the Ministry of Health this afternoon to prepare guidance for doctors and pharmacists to help them manage this process—including in situations where an alternative antibiotic needs to be prescribed.  If a doctor feels comfortable doing so, a Standing Order to the pharmacy can be issued and a template for this purpose has been provided.

If you have any questions or concerns, please contact us at nzma@nzma.org.nz.